Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,319,998,477
-$282,606,703 QoQ
Shares Held
96,345,452
+3.9% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#7
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. PFE ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
This page
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,319,998,477 | 96,345,452 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,602,605,180 | 92,685,370 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,218,928,732 | 89,113,604 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,905,156,358 | 74,770,658 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,700,079,857 | 70,135,308 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,038,408,306 | 80,442,317 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,960,508,361 | 73,897,790 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,256,486,983 | 77,971,216 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,167,673,434 | 77,472,246 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $2,353,001,276 | 84,792,839 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,363,847,160 | 82,106,536 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,817,055,179 | 84,927,802 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,102,364,092 | 84,579,174 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,290,496,696 | 80,649,429 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,073,547,250 | 79,499,361 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,154,195,937 | 72,079,432 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,803,714,441 | 72,548,435 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,452,590,647 | 47,374,747 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,778,529,600 | 47,053,846 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,006,589,610 | 46,654,025 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,875,532,168 | 47,894,080 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,677,884,769 | 46,312,028 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,973,388,182 | 53,610,111 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,690,762,410 | 46,069,866 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,415,656,072 | 43,292,190 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,481,987,386 | 45,404,087 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||